Skip to main content

This job has expired

You will need to login before you can apply for a job.

Senior Research Associate, Analytical Development

Employer
Sutro Biopharma, Inc
Location
South San Francisco, CA
Salary
$105,000 - $135,000
Start date
Jun 1, 2024

Job Details

Sutro Biopharma, Inc. is looking for a Senior Research Associate to join our Analytical Development group to support chromatography and mass spectrometry analyses for antibodies (mAb), bispecific antibodies (bsAb), antibody drug conjugates (ADCs), immunostimulatory antibody drug conjugate (iADCs) and cytokine derivatives.  Responsibilities: 
  • Perform routine chromatography assays to support upstream, downstream, and formulation process development.
  • Process and interpret data from assays to communicate and present to internal and external colleagues.
  • Develop chromatography assays for characterization of recombinant proteins such as antibody derivatives.
  • Qualify assays and support technology transfer to Sutro QC, and to partner and contract testing laboratories.
  • Author and review SOPs, protocols, and technical reports
  • Engage collaboratively within Analytical Development, other functional areas, external partners, and CMOs.
  • Perform routine maintenance and troubleshoot HPLCs and other separations-based instrumentation.

Qualifications: 
  • BS/MS in analytical chemistry, biochemistry, molecular biology or related scientific field and 2+ years of industry experience in the characterization of large molecule biologics is required.
  • Experience with operating and maintaining of HPLCs & UHPLCs is highly preferred.
  • Experience with data processing software such as Chromeleon, OpenLab ChemStation, or Empower is preferred.
  • Understanding of some separation methods (Protein A/G/L, RP, IEX, SEC, HIC, HILIC) is preferred.
  • Experience with method development, qualification, and method transfer to a QC environment is a plus.
  • Knowledge of alternative detection modules such as FLD, MALS, ELSD, and/or CAD is a plus.
  • Knowledge of additional analytical techniques such as iCIEF, mCE-SDS (Caliper), and/or CE-SDS is a plus.
  • Flexibility to work on multiple projects and communicate effectively in a fast-paced environment is essentials.

    Sound exciting? Apply today and join our team!
Sutro Biopharma, Inc. encourages all colleagues to be fully vaccinated for COVID-19 prior to the first date of employment.   As an equal opportunity employer, we believe in fostering a culture that is inclusive and values diversity in background and opinions. Sutro Biopharma hires extraordinary individuals into every position in the company and is committed to the diversity of our team. Our company progresses without regard of race, ethnicity, gender, sexual orientation, religious belief, age, disability, or citizenship status. We are dedicated to creating a safe environment where our employees can grow and succeed together. We look forward to hearing from candidates who are interested in exploring opportunities with Sutro! Our People & Culture team/hiring managers are unable to respond and do not accept solicitations from third-party agencies.     The anticipated salary range for fully qualified candidates applying for this role at Sutro Biopharma’s California-based locations will be $105,000 - $135,000. The final salary offered will be dependent on several factors that include and are not limited to relevant previous experience, job responsibilities and duration of experience, the type and length of experience within the industry, and education.     About Sutro Biopharma   Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.    

Company

sutro

 

Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.

Stock Symbol: STRO

Twitter

 

yh

Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more" - view it here 

erf

 

Company info
Website
Phone
650.881.6500
Location
111 Oyster Point Blvd
South San Francisco
California
94080
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert